COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RA PATIENTS IN THE NETHERLANDS

被引：0
|
作者：
Diamantopoulos, A. [1 ]
Kievit, W. [2 ]
De Vries, R. [3 ]
Pompen, M. [3 ]
机构：
[1] Symmetron Ltd, Elstree, Herts, England
[2] Dutch Rheumatoid Arthritis Monitoring Register, Nijmegen, Netherlands
[3] Roche, Woerden, Netherlands
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.435
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A311 / A311
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF TIOTROPIUM IN THE TREATMENT OF PATIENTS WITH ASTHMA
    Echave, M.
    Ojanguren, M. E.
    Elias, I
    de Andres-Nogales, F.
    Oyaguez, I
    Casado, M. A.
    Crespo, C.
    VALUE IN HEALTH, 2015, 18 (07) : A501 - A502
  • [32] The cost-effectiveness of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA) in Denmark
    Aagren, M.
    Davies, A.
    Winding, B.
    Cifaldi, M.
    Pang, F.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 15 - 15
  • [33] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE IN THE NETHERLANDS
    Fens, T.
    Weersma, M.
    Postma, M. J.
    Boersma, C.
    de Jong, L.
    VALUE IN HEALTH, 2023, 26 (12) : S132 - S132
  • [34] Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden
    Kasteng, Frida
    Erlanson, Martin
    Hagberg, Hans
    Kimby, Eva
    Relander, Thomas
    Lundkvist, Jonas
    ACTA ONCOLOGICA, 2008, 47 (06) : 1029 - 1036
  • [35] Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
    Sonja Merkesdal
    Timm Kirchhoff
    Diane Wolka
    Gunter Ladinek
    Adrian Kielhorn
    Andrea Rubbert-Roth
    The European Journal of Health Economics, 2010, 11 : 95 - 104
  • [36] EVALUATING THE COST-EFFECTIVENESS OF THE ADDITION OF RITUXIMAB TO CHEMOTHERAPY IN THE FIRST LINE TREATMENT OF FOLLICULAR LYMPHOMA PATIENTS IN THE UK
    Rafia, R.
    Papaioannou, D.
    Stevenson, M.
    Rathbone, J.
    Woods, H. B.
    VALUE IN HEALTH, 2011, 14 (07) : A445 - A445
  • [37] Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
    Merkesdal, Sonja
    Kirchhoff, Timm
    Wolka, Diane
    Ladinek, Gunter
    Kielhorn, Adrian
    Rubbert-Roth, Andrea
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2010, 11 (01): : 95 - 104
  • [38] Cost-effectiveness of pertussis booster vaccination in the Netherlands
    Rozenbaum, Mark H.
    De Cao, Elisabetta
    Postma, Maarten J.
    VACCINE, 2012, 30 (50) : 7327 - 7331
  • [39] COST-EFFECTIVENESS OF DIAGNOSING AXIAL SPONDYLOARTHRITIS IN THE NETHERLANDS
    Webers, C.
    Grimm, S.
    Van Tubergen, A.
    Van Gaalen, F. A.
    Van der Heijde, D.
    Joore, M.
    Boonen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 510 - 511
  • [40] Cost-effectiveness of atorvastatin compared to simvastatin in the Netherlands
    Severens, JL
    Prins, MH
    Monteban, HC
    VALUE IN HEALTH, 2003, 6 (06) : 671 - 671
12345